Loading clinical trials...
Loading clinical trials...
A Prospective Single Arm Trial of Neoadjuvant Chemo-immunotherapy Followed by Concurrent Chemoradiotherapy and Immunotherapy in Locally Advanced Cervical Cancer
Conditions
Interventions
Neoadjuvant Chemotherapy (NACT)
Locations
1
China
Renji Hospital
Shanghai, Shanghai Municipality, China
Start Date
April 5, 2025
Primary Completion Date
December 30, 2026
Completion Date
December 30, 2028
Last Updated
April 8, 2025
NCT05975593
NCT07104149
NCT05378087
NCT05950087
NCT05311566
NCT06943833
Lead Sponsor
RenJi Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions